De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Encompass Health Beheer
Beheer criteriumcontroles 4/4
De CEO Encompass Health's is Mark Tarr, benoemd in Dec2016, heeft een ambtstermijn van 7.83 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 8.84M, bestaande uit 11.9% salaris en 88.1% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.55% van de aandelen van het bedrijf, ter waarde $ 53.55M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 11.2 jaar en 4.8 jaar.
Belangrijke informatie
Mark Tarr
Algemeen directeur
US$8.8m
Totale compensatie
| Percentage CEO-salaris | 11.9% |
| Dienstverband CEO | 7.8yrs |
| Eigendom CEO | 0.6% |
| Management gemiddelde ambtstermijn | 11.2yrs |
| Gemiddelde ambtstermijn bestuur | 4.8yrs |
Recente managementupdates
Recent updates
Is Encompass Health (NYSE:EHC) Using Too Much Debt?
Oct 03
Encompass Health's (NYSE:EHC) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 27Encompass Health (NYSE:EHC) Will Pay A Larger Dividend Than Last Year At $0.17
Aug 10These 4 Measures Indicate That Encompass Health (NYSE:EHC) Is Using Debt Reasonably Well
Jun 27Do Encompass Health's (NYSE:EHC) Earnings Warrant Your Attention?
Jun 09Encompass Health Corporation's (NYSE:EHC) Business Is Yet to Catch Up With Its Share Price
May 23Encompass Health Corporation Just Beat EPS By 20%: Here's What Analysts Think Will Happen Next
Apr 26Is Encompass Health Corporation (NYSE:EHC) Expensive For A Reason? A Look At Its Intrinsic Value
Apr 11Encompass Health's (NYSE:EHC) Dividend Will Be $0.15
Mar 09What Is Encompass Health Corporation's (NYSE:EHC) Share Price Doing?
Feb 25Do Encompass Health's (NYSE:EHC) Earnings Warrant Your Attention?
Feb 07We Think Encompass Health (NYSE:EHC) Can Stay On Top Of Its Debt
Jan 09Encompass Health (NYSE:EHC) Has Announced A Dividend Of $0.15
Dec 13Encompass Health (NYSE:EHC) Is Due To Pay A Dividend Of $0.15
Nov 28Is There Now An Opportunity In Encompass Health Corporation (NYSE:EHC)?
Nov 21Are Encompass Health Corporation (NYSE:EHC) Investors Paying Above The Intrinsic Value?
Nov 08Is Encompass Health (NYSE:EHC) A Risky Investment?
Oct 10Do Encompass Health's (NYSE:EHC) Earnings Warrant Your Attention?
Sep 07Encompass Health Corporation: Solid Quarterly Report Makes For A Buy
Aug 14What Does Encompass Health Corporation's (NYSE:EHC) Share Price Indicate?
Aug 10Encompass Health: Incremental CapEx Adds Tremendous Torque To Flywheel
Aug 07Encompass Health (NYSE:EHC) Is Paying Out A Dividend Of $0.15
Jul 23Does Encompass Health (NYSE:EHC) Have A Healthy Balance Sheet?
May 22Is Now The Time To Look At Buying Encompass Health Corporation (NYSE:EHC)?
May 01Encompass Health declares $0.15 dividend
Feb 23Encompass Health: Incremental Returns On Capital Key, Confirm Buy
Feb 17Encompass Health 2023 adjusted earnings per share estimate range below consensus
Feb 07Is Now An Opportune Moment To Examine Encompass Health Corporation (NYSE:EHC)?
Jan 23Encompass Health Non-GAAP EPS of $0.67 beats by $0.03, revenue of $1.09B beats by $30M
Oct 26Encompass Health declares $0.15 dividend
Oct 19Should You Investigate Encompass Health Corporation (NYSE:EHC) At US$48.81?
Oct 18Encompass health to build a rehabilitation hospital in the Villages, Florida
Sep 26Encompass Health Encompasses Quality, Defensibility After Q2 FY22
Aug 10Encompass Health Q2 2022 Earnings Preview
Jul 31Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$409m |
| Mar 31 2024 | n/a | n/a | US$387m |
| Dec 31 2023 | US$9m | US$1m | US$362m |
| Sep 30 2023 | n/a | n/a | US$357m |
| Jun 30 2023 | n/a | n/a | US$336m |
| Mar 31 2023 | n/a | n/a | US$280m |
| Dec 31 2022 | US$8m | US$1m | US$256m |
| Sep 30 2022 | n/a | n/a | US$232m |
| Jun 30 2022 | n/a | n/a | US$242m |
| Mar 31 2022 | n/a | n/a | US$253m |
| Dec 31 2021 | US$8m | US$1m | US$298m |
| Sep 30 2021 | n/a | n/a | US$316m |
| Jun 30 2021 | n/a | n/a | US$318m |
| Mar 31 2021 | n/a | n/a | US$304m |
| Dec 31 2020 | US$7m | US$953k | US$193m |
| Sep 30 2020 | n/a | n/a | US$265m |
| Jun 30 2020 | n/a | n/a | US$285m |
| Mar 31 2020 | n/a | n/a | US$342m |
| Dec 31 2019 | US$7m | US$1m | US$358m |
| Sep 30 2019 | n/a | n/a | US$317m |
| Jun 30 2019 | n/a | n/a | US$308m |
| Mar 31 2019 | n/a | n/a | US$309m |
| Dec 31 2018 | US$6m | US$963k | US$290m |
| Sep 30 2018 | n/a | n/a | US$339m |
| Jun 30 2018 | n/a | n/a | US$316m |
| Mar 31 2018 | n/a | n/a | US$288m |
| Dec 31 2017 | US$5m | US$900k | US$271m |
Compensatie versus markt: De totale vergoeding ($USD 8.84M ) Mark } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 8.11M ).
Compensatie versus inkomsten: De vergoeding van Mark is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Mark Tarr (62 yo)
7.8yrs
Tenure
US$8,836,376
Compensatie
Mr. Mark J. Tarr serves as Director at Protective Life Corporation since April 04, 2023. He serves as President, Chief Executive Officer and Director of Encompass Health Corp. since December 29, 2016. He s...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO, President & Director | 7.8yrs | US$8.84m | 0.55% $ 52.4m | |
| Executive VP & CFO | 14.4yrs | US$5.75m | 0.26% $ 24.7m | |
| Senior VP & Chief Accounting Officer | 15yrs | US$1.10m | 0.076% $ 7.2m | |
| Executive VP | 8.7yrs | US$3.17m | 0.084% $ 8.0m | |
| Chief Medical Officer | 9.3yrs | US$1.30m | 0.018% $ 1.8m | |
| Chief Information Officer & Senior VP | 13.3yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Investor Relations & Strategic Planning | 3.1yrs | geen gegevens | geen gegevens | |
| Chief Compliance Officer | 9.3yrs | geen gegevens | geen gegevens | |
| Chief Human Resources Officer | 4.8yrs | geen gegevens | geen gegevens | |
| President of Southwest Region | 13.1yrs | geen gegevens | geen gegevens | |
| President of West Region | 13.1yrs | geen gegevens | geen gegevens | |
| President of Northeast Region | 16.3yrs | geen gegevens | geen gegevens |
11.2yrs
Gemiddelde duur
60.5yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van EHC is doorgewinterd en ervaren (gemiddelde ambtstermijn van 11.2 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO, President & Director | 7.8yrs | US$8.84m | 0.55% $ 52.4m | |
| Independent Director | 11.8yrs | US$289.80k | 0.00099% $ 94.1k | |
| Independent Director | 11.8yrs | US$294.80k | 0.00099% $ 94.1k | |
| Independent Director | 6.8yrs | US$259.79k | 0.000040% $ 3.8k | |
| Independent Chairman | 4.8yrs | US$276.01k | 0.0038% $ 362.3k | |
| Independent Director | 4.8yrs | US$256.01k | 0.000020% $ 1.9k | |
| Independent Director | 3yrs | US$272.98k | 0.012% $ 1.1m | |
| Director | less than a year | US$74.45k | 0.00049% $ 46.6k | |
| Independent Director | 2.6yrs | US$252.54k | 0.0010% $ 96.0k | |
| Independent Director | 4.8yrs | US$271.01k | 0.00035% $ 33.3k |
4.8yrs
Gemiddelde duur
64.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van EHC wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.8 jaar).